Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report What's New in this Update? Methodology Information Sources Geographic Breakdown Segmentation Breakdown Chapter 2 Summary and Highlights Market Outlook Highlights of the Market for Advanced Drug Delivery Systems Chapter 3 Market Overview Overview Evolution of Advanced Drug Delivery Systems Chapter 4 Market Dynamics Overview Market Drivers Market Restraints Market Opportunities Impact of COVID-19 on the ADDS Market Chapter 5 Evaluation of the Market Based on Technology Overview of Advanced Drug Delivery Systems and Technologies Market Share and Forecast Immediate-Release Drug Delivery Extended-Release Drug Delivery Targeted-Release Drug Delivery Delayed-Release Drug Delivery Pulsatile-Release Drug Delivery Chapter 6 Evaluation of the Market Based on Route of Administration Overview of Routes of Administration of Drugs Market Share and Forecast Oral Parenteral/Injectable Transmucosal Transmucosal Nasal and Pulmonary Transmucosal Ocular Transmucosal Rectal Transmucosal Oral Buccal Transmucosal Vaginal Implant Transdermal Topical Chapter 7 Evaluation of the Market Based on Vehicle/Carrier Overview of Vehicles/Carriers Used in Advanced Drug Delivery Systems Market Share and Forecast Nanoparticles Monoclonal Antibodies Liposomes Polymeric Therapeutics Dendrimers Polymeric Drug Polymeric Micelles Prodrugs Microparticles Others Chapter 8 Evaluation of the Market Based on Application Overview of Applications Used in Advanced Drug Delivery Systems Market Share and Forecast Oncology Inflammatory Diseases and Allergies Cardiovascular Ophthalmic Central Nervous System Hormone Replacement Therapy and Gynecology Viral and Bacterial Diseases Diabetes Urology Gastrointestinal (GI) Disorders Dermatology Respiratory Other Therapeutic Chapter 9 Evaluation of the Market Based on Geographic Region Global Market for ADDS by Region North America Europe Asia-Pacific Rest of the World (RoW) Chapter 10 ESG Development Introduction to ESG Sustainability in the Advanced Drug Delivery Systems (ADDS) Industry: An ESG Perspective Key ESG Issues ESG Risk Rankings Consumer Attitudes toward ESG in the ADDS Market Case Study Concluding Remarks from BCC Chapter 11 Emerging Technologies in the Market Emerging Technology, ADDS Market 3D Printing Technology in Drug Delivery Biologics Drug Delivery AI in Drug Delivery Smart Drug Delivery System Chapter 12 Clinical Trials and Patent Analysis Clinical Trials Analysis Clinical Trials Analysis by Type of Study Clinical Trials Analysis by Status Clinical Trials Analysis by Phase Clinical Trials Analysis by Region Patent Analysis Patents by Year Patents by Top Applicant Patents by Top Owner Patents by Jurisdiction Chapter 13 Competitive Intelligence Market Share Analysis Recent Developments of Key Market Players Chapter 14 Company Profiles ABBOTT ABBVIE INC. ASTRAZENECA BD BOSTON SCIENTIFIC CORP. F. HOFFMANN-LA ROCHE LTD JOHNSON & JOHNSON SERVICES INC. KINDEVA DRUG DELIVERY MEDTRONIC MERCK & CO. INC. NOVARTIS AG PFIZER INC. SANOFI S.A. TERUMO CORP. TEVA PHARMACEUTICAL INDUSTRIES LTD. Chapter 15 Appendix: Acronyms
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook